CHARLES P. HART,JESSICA D. SUN,BRIAN A. ELENBAAS,ANTONIO GUALBERTO
申请号：
US14907190
公开号：
US20160158253A1
申请日:
2014.07.23
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Combined administration of a hypoxia-activated prodrug, such as TH-302, a taxane, such as nab-paclitaxel, and a nucleoside analog chemotherapeutic, such as gemcitabine, are efficacious in the treatment of cancer, including pancreatic cancer.
